Trials / Completed
CompletedNCT00610597
Study of T Cell Phenotype Activation Pathway in Human Alcoholic Liver Disease
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 49 (actual)
- Sponsor
- Erasme University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Alcoholic liver disease is characterized by circulating T cell activation and liver T cell infiltration but their phenotype is poorly studied. The aim of the study is to test the hypothesis that the (CD4+ T cell secreting Interleukin-17) Th17 pathway is involved in alcoholic liver disease.
Detailed description
Consecutive patients undergoing transjugular liver biopsies for alcoholic liver disease or hepatitis C virus infection will be included in the study to measure plasma cytokines levels, peripheral blood mononuclear cells cytokine release and liver T cell infiltrates.
Conditions
Timeline
- Start date
- 2005-01-01
- Primary completion
- 2007-01-01
- Completion
- 2008-01-01
- First posted
- 2008-02-08
- Last updated
- 2008-02-08
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT00610597. Inclusion in this directory is not an endorsement.